{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:50:57Z","timestamp":1762660257727,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T00:00:00Z","timestamp":1635897600000},"content-version":"am","delay-in-days":275,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004755","name":"EMD Serono","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004755","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["QLG1-CT-2001-01252"],"award-info":[{"award-number":["QLG1-CT-2001-01252"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006356","name":"Syddansk Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006356","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.bone.2020.115681","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T22:21:44Z","timestamp":1602022904000},"page":"115681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Serum sclerostin and glucose homeostasis: No association in healthy men. Cross-sectional and prospective data from the EGIR-RISC study"],"prefix":"10.1016","volume":"143","author":[{"given":"Jens-Jacob L.","family":"Lauterlein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pernille","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Konrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael Gabriel","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ele","family":"Ferrannini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2021-413X","authenticated-orcid":false,"given":"Beverley","family":"Balkau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt","family":"H\u00f8jlund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Frost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.bone.2020.115681_bb0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mce.2009.04.004","article-title":"A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms","volume":"310","author":"Confavreux","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"issue":"2","key":"10.1016\/j.bone.2020.115681_bb0010","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cell.2010.06.002","article-title":"Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition","volume":"142","author":"Fulzele","year":"2010","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bone.2020.115681_bb0015","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3803\/EnM.2018.33.3.318","article-title":"Regulation of osteoblast metabolism by Wnt signaling","volume":"33","author":"Moorer","year":"2018","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"9","key":"10.1016\/j.bone.2020.115681_bb0020","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1074\/jbc.M705092200","article-title":"Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost\/sclerostin","volume":"283","author":"Robling","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bone.2020.115681_bb0025","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1073\/pnas.0133792100","article-title":"Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion","volume":"100","author":"Fujino","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.bone.2020.115681_bb0030","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2265.2009.03680.x","article-title":"Low density lipoprotein receptor-related protein 5 (LRP5) mutations and osteoporosis, impaired glucose metabolism and hypercholesterolaemia","volume":"72","author":"Saarinen","year":"2010","journal-title":"Clin. Endocrinol."},{"issue":"2","key":"10.1016\/j.bone.2020.115681_bb0035","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.cmet.2015.01.009","article-title":"LRP5 regulates human body fat distribution by modulating adipose progenitor biology in a dose- and depot-specific fashion","volume":"21","author":"Loh","year":"2015","journal-title":"Cell Metab."},{"issue":"7","key":"10.1016\/j.bone.2020.115681_bb0040","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng.609","article-title":"Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis","volume":"42","author":"Voight","year":"2010","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.bone.2020.115681_bb0045","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/dc14-2989","article-title":"Sclerostin and insulin resistance in prediabetes: evidence of a cross talk between bone and glucose metabolism","volume":"38","author":"Daniele","year":"2015","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.bone.2020.115681_bb0050","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/jc.2011-2186","article-title":"Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus","volume":"97","author":"Garcia-Martin","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.bone.2020.115681_bb0055","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/cen.12364","article-title":"Clinical and endocrine correlates of circulating sclerostin levels in patients with type 1 diabetes mellitus","volume":"80","author":"Neumann","year":"2014","journal-title":"Clin. Endocrinol."},{"issue":"4","key":"10.1016\/j.bone.2020.115681_bb0060","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/cen.13300","article-title":"The association between sclerostin and incident type 2 diabetes risk: a cohort study","volume":"86","author":"Yu","year":"2017","journal-title":"Clin. Endocrinol."},{"issue":"7","key":"10.1016\/j.bone.2020.115681_bb0065","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s00198-016-3540-8","article-title":"Has sclerostin a true endocrine metabolic action complementary to osteocalcin in older men?","volume":"27","author":"Confavreux","year":"2016","journal-title":"Osteoporos. Int."},{"issue":"1","key":"10.1016\/j.bone.2020.115681_bb0070","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2011-2152","article-title":"Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults","volume":"97","author":"Amrein","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2020.115681_bb0075","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijcard.2016.03.072","article-title":"Circulating sclerostin levels and cardiovascular risk in obesity","volume":"214","author":"Popovic","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bone.2020.115681_bb0080","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bone.2016.10.011","article-title":"Serum sclerostin decreases following 12months of resistance- or jump-training in men with low bone mass","volume":"96","author":"Hinton","year":"2017","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.bone.2020.115681_bb0085","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13695","article-title":"Circulating sclerostin is not suppressed following a single bout of exercise in young men","volume":"6","author":"Guerriere","year":"2018","journal-title":"Physiol Rep"},{"issue":"3","key":"10.1016\/j.bone.2020.115681_bb0090","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00125-004-1335-5","article-title":"The EGIR-RISC STUDY (the European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives","volume":"47","author":"Hills","year":"2004","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.bone.2020.115681_bb0095","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","article-title":"International physical activity questionnaire: 12-country reliability and validity","volume":"35","author":"Craig","year":"2003","journal-title":"Med. Sci. Sports Exerc."},{"issue":"10","key":"10.1016\/j.bone.2020.115681_bb0100","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.2337\/db07-1605","article-title":"Physical activity and insulin sensitivity: the RISC study","volume":"57","author":"Balkau","year":"2008","journal-title":"Diabetes"},{"issue":"39","key":"10.1016\/j.bone.2020.115681_bb0105","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"Authors\/Task Force, M","year":"2013","journal-title":"Eur Heart J"},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2020.115681_bb0110","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc19-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019","volume":"42","author":"American Diabetes, A","year":"2019","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.bone.2020.115681_bb0115","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.bone.2020.115681_bb0120","doi-asserted-by":"crossref","first-page":"E1159","DOI":"10.1152\/ajpendo.00093.2002","article-title":"Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects","volume":"283","author":"Mari","year":"2002","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.bone.2020.115681_bb0125","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.2337\/db11-0827","article-title":"Influence of hyperinsulinemia and insulin resistance on in vivo beta-cell function: their role in human beta-cell dysfunction","volume":"60","author":"Mari","year":"2011","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.bone.2020.115681_bb0130","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabet. Med."},{"key":"10.1016\/j.bone.2020.115681_bb0135","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bone.2017.12.029","article-title":"The relationship between bone turnover and insulin sensitivity and secretion: cross-sectional and prospective data from the RISC cohort study","volume":"108","author":"Frost","year":"2018","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.bone.2020.115681_bb0140","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1002\/jbmr.479","article-title":"Determinants of serum sclerostin in healthy pre- and postmenopausal women","volume":"26","author":"Ardawi","year":"2011","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2020.115681_bb0145","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2337\/diacare.24.3.539","article-title":"A model-based method for assessing insulin sensitivity from the oral glucose tolerance test","volume":"24","author":"Mari","year":"2001","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.bone.2020.115681_bb0150","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nrendo.2016.153","article-title":"Mechanisms of diabetes mellitus-induced bone fragility","volume":"13","author":"Napoli","year":"2017","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"10.1016\/j.bone.2020.115681_bb0155","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S8756-3282(02)00728-7","article-title":"Effect of feeding on bone turnover markers and its impact on biological variability of measurements","volume":"30","author":"Clowes","year":"2002","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bone.2020.115681_bb0160","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1530\/EJE-19-0309","article-title":"The diurnal variation of bone formation is attenuated in adult patients with type 2 diabetes","volume":"181","author":"Hygum","year":"2019","journal-title":"Eur. J. Endocrinol."},{"issue":"10","key":"10.1016\/j.bone.2020.115681_bb0165","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1177\/002215540004801006","article-title":"Expression of the type I diabetes-associated gene LRP5 in macrophages, vitamin A system cells, and the Islets of Langerhans suggests multiple potential roles in diabetes","volume":"48","author":"Figueroa","year":"2000","journal-title":"The journal of histochemistry and cytochemistry: official journal of the Histochemistry Society"},{"issue":"5","key":"10.1016\/j.bone.2020.115681_bb0170","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1210\/jc.2017-02274","article-title":"Serum sclerostin and bone turnover in latent autoimmune diabetes in adults","volume":"103","author":"Napoli","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"16","key":"10.1016\/j.bone.2020.115681_bb0175","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.bone.2020.115681_bb0180","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s00223-015-0105-3","article-title":"How accurate is your sclerostin measurement? Comparison between three commercially available sclerostin ELISA kits","volume":"98","author":"Piec","year":"2016","journal-title":"Calcif. Tissue Int."},{"issue":"1","key":"10.1016\/j.bone.2020.115681_bb0185","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1479164113510923","article-title":"The relationship between inhibitors of the Wnt signalling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus","volume":"11","author":"Gaudio","year":"2014","journal-title":"Diab. Vasc. Dis. Res."},{"issue":"6","key":"10.1016\/j.bone.2020.115681_bb0190","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.2337\/dc12-1691","article-title":"Atherosclerotic disease in type 2 diabetes is associated with an increase in sclerostin levels","volume":"36","author":"Morales-Santana","year":"2013","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.bone.2020.115681_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199504","article-title":"Circulating levels of sclerostin are associated with cardiovascular mortality","volume":"13","author":"Novo-Rodriguez","year":"2018","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.bone.2020.115681_bb0200","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1074\/mcp.M110.001693","article-title":"Proteomics characterization of extracellular space components in the human aorta","volume":"9","author":"Didangelos","year":"2010","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bone.2020.115681_bb0205","first-page":"107469","article-title":"Improved carotid intima-media thickness-induced high-intensity interval training associated with decreased serum levels of Dkk-1 and sclerostin in type 2 diabetes","author":"Ghardashi-Afousi","year":"2019","journal-title":"J. Diabetes Complicat."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220304610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220304610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:42:42Z","timestamp":1762659762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328220304610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":41,"alternative-id":["S8756328220304610"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2020.115681","relation":{},"ISSN":["8756-3282"],"issn-type":[{"type":"print","value":"8756-3282"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum sclerostin and glucose homeostasis: No association in healthy men. Cross-sectional and prospective data from the EGIR-RISC study","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2020.115681","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115681"}}